Evidence map›Paper›PMID 32519382›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

An opt-out model for kidney transplant referral: The time has come.

Anne M Huml, John R Sedor, Emilio Poggio, Rachel E Patzer, Jesse D Schold

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Referral and Beyond: Restructuring the Kidney Transplant Process to Support Greater Access in the United States.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Dialysis and Transplant Access: Kidney Capitalism at a Crossroads?Clinical journal of the American Society of Nephrology : CJASN · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anne M HumlDepartment of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-6224-0785
John R SedorDepartment of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Emilio PoggioDepartment of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Rachel E PatzerDepartment of Surgery, Division of Transplantation, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0003-2573-9963
Jesse D ScholdDepartment of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-5341-7286
Cleveland Clinic · USEmory University · US

Funding

Barriers to Care for Patients Transitioning from Transplant to DialysisK23DK101492 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI HUML, ANNE MARIE · 2016 to 2020
$800k
NIDDK NIH HHS K23 DK101492
6 · The paper itself

Abstract

Disparities that affect equity in access to kidney transplantation for patients with kidney failure have been well described. Many robust clinical trials have tested the effectiveness of interventions to reduce disparities and equilibrate access to kidney transplantation. Moreover, policy changes have been enacted to achieve the same aims. Despite these efforts, rates of kidney transplant waitlisting within the first year of end-stage kidney disease have remained unchanged over the past 2 decades, while incident rates of end-stage kidney disease have climbed. Because prior interventions have not durably increased transplant access, disruptive change is clearly needed. The Advancing American Kidney Health Executive Order sets bold goals to transform kidney care for patients and caregivers. In this spirit, we discuss an Opt-Out for Transplant Referral Model as a compelling solution to improve equity in access to kidney transplantation.

Indexed as

Kidney Failure, ChronicKidney TransplantationHumansKidneyReferral and ConsultationUnited StatesWaiting Listseditorial/personal viewpointguidelineskidney transplantation/nephrologyquality of care/care deliverywaitlist management

Identifiers

PMID32519382
PMCPMC7725926
OpenAlexW3033832679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.